Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects.

[1]  G. Funk,et al.  Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. , 2003, Chest.

[2]  J. Wharton,et al.  Pulmonary arterial hypertension and the vasoconstrictive factor: is there still a role for vasodilator testing? , 2003, European heart journal.

[3]  N. Morrell,et al.  Molecular and cellular basis of pulmonary vascular remodeling in pulmonary hypertension. , 2002, Progress in cardiovascular diseases.

[4]  A. Branzi,et al.  Emerging medical therapies for pulmonary arterial hypertension. , 2002, Progress in cardiovascular diseases.

[5]  W. Seeger,et al.  Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial , 2002, The Lancet.

[6]  N. Pereira,et al.  Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. , 2002, The American journal of cardiology.

[7]  M. Humbert,et al.  Primary pulmonary hypertension: Current therapy. , 2002, Progress in cardiovascular diseases.

[8]  Gilles Garcia,et al.  Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.

[9]  R. Hetzer,et al.  Assessment of Survival in Patients With Primary Pulmonary Hypertension: Importance of Cardiopulmonary Exercise Testing , 2002, Circulation.

[10]  C. Narasimhan,et al.  A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension. , 2002, Indian heart journal.

[11]  S. Archer,et al.  Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension Comparison With Inhaled Nitric Oxide , 2002 .

[12]  E. Michelakis,et al.  Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide , 2002, Circulation.

[13]  G. Sybrecht,et al.  Effect of Inhaled Iloprost Plus Oral Sildenafil in Patients With Primary Pulmonary Hypertension , 2001, Circulation.

[14]  J. E. Hansen,et al.  Exercise Pathophysiology in Patients With Primary Pulmonary Hypertension , 2001, Circulation.

[15]  N. Morrell,et al.  Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension , 2001, Circulation.

[16]  S. Rich,et al.  Primary pulmonary hypertension: a vascular biology and translational research "Work in progress". , 2000, Circulation.

[17]  M. Gatzoulis,et al.  Sildenafil in primary pulmonary hypertension. , 2000, The New England journal of medicine.

[18]  M. Hoeper,et al.  Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. , 2000, The New England journal of medicine.

[19]  W. Zapol,et al.  Sildenafil Is a Pulmonary Vasodilator in Awake Lambs with Acute Pulmonary Hypertension , 2000, Anesthesiology.

[20]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[21]  D. Gibson,et al.  Left ventricular filling characteristics in pulmonary hypertension: a new mode of ventricular interaction , 1992, British heart journal.

[22]  J. Gardin,et al.  Evaluation of pulmonary artery pressure and resistance by pulsed Doppler echocardiography. , 1987, The American journal of cardiology.

[23]  B. Brundage,et al.  Doppler echocardiography assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension , 1986 .

[24]  M. J. Conley,et al.  An echocardiographic index for separation of right ventricular volume and pressure overload. , 1985, Journal of the American College of Cardiology.

[25]  M. Hori,et al.  ECHOCARDIOGRAPHV-DOPPLER Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique , 2005 .